The director of the National Institutes of Health (NIH) has said the federal government’s discontinuation of mRNA vaccine ...

The activist investor Engine Capital is lobbying for big changes at Avantor, urging the life science toolmaker to either cut ...

After the Department of Health and Human Services canceled about $500 million in funding for mR | After HHS abruptly canceled ...

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...

The company said its CGM+ system can deliver accurate readings across a 15-day lifespan, while also employing fewer ...

Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine ...

A day after posting a pair of phase 3 wins for the tricky indication of Sjögren's syndrome, the Swiss pharma has unveiled a ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...

More bad news has come down for Biohaven’s small molecule troriluzole. | More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee ...

Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...

IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...

Young inflammatory disease biotech Expedition Therapeutics is paying $17 million cash for licensing rights to an ...